Clinical Trial Update: Dexmedetomidine Improves the Surgical Field and Postoperative Recovery of Nasal Endoscopic Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial update suggesting dexmedetomidine improves the surgical field quality and postoperative recovery in nasal endoscopic surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Obstruction
• Nasal Polyps Nasal Endoscopic Surgery Context Indicates Nasal Surgery Disease Not Explicitly Stated in Snippet
• Sinus Disease

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Eye & ENT Hospital of Fudan University | Conditions: Dexmedetomidine, Bleeding | Phase 3 | Status: COMPLETED